An understanding of myogenesis and cardiac cell proliferation and differentiation must involve multiple, complex systems for controlling gene regulation during development. The cytoskeletal proteins, vimentin and desmin, provide an excellent model system for deciphering how genes are """"""""turned-off"""""""" or activated during cardiac differentiation. Vimentin synthesis is first detected at the delineation of the mesoderm. A number of cell-types differentiate from this lineage and continue to synthesize vimentin, whereas others like heart """"""""turn-off"""""""" the vimentin gene and activate the muscle-specific gene, desmin. The goal of this proposal is to determine what is required for the inactivation of the vimentin gene. Obviously, any defect in this early developmental decision could result in aberrant gene expression and compromise cardiac development. Previous work suggests multiple positive and at least one negative factor is required for vimentin expression in muscle tissue. The negative protein factor accumulates during embryogenesis which is responsible at least in part for turning-off the vimentin gene. This silencer protein appears early in chick heart development and increases 14-fold by day 18 in ovo. this increase roughly parallels the decline in vimentin mRNA which is barely detectable in chickens by six days of age. A comparable protein is found in mouse, rat and human cells and, therefore, it appears universal to most model developmental systems. Because the silencer protein is fairly abundant in heart, we suspect it is important for the regulation of other genes in addition to vimentin. In fact, it may also serve to coordinate cell growth and gene not clear whether or not myocytes are reversibly withdrawn from cell-cycle during development. The goal of this proposal is to characterize these cis-acting sequences and protein factors involved in vimentin gene regulation during cardiac development. Due to its novelty particular emphasis will be placed on the silencer protein. Here, positive factors involved in vimentin gene regulation and what other genes might be subjected to this regulation. Ultimately, we will isolate the silencer protein, its cDNA and gene. An understanding of how the silencer gene is regulated, is vital in determining how developmental decisions are made early in cardiac embryogenesis.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL045422-01
Application #
3364396
Study Section
Special Emphasis Panel (SRC (DW))
Project Start
1990-07-01
Project End
1995-04-30
Budget Start
1990-07-01
Budget End
1991-04-30
Support Year
1
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Salmon, Morgan; Owens, Gary K; Zehner, Zendra E (2009) Over-expression of the transcription factor, ZBP-89, leads to enhancement of the C2C12 myogenic program. Biochim Biophys Acta 1793:1144-55
Salmon, Morgan; Zehner, Zendra E (2009) The transcriptional repressor ZBP-89 and the lack of Sp1/Sp3, c-Jun and Stat3 are important for the down-regulation of the vimentin gene during C2C12 myogenesis. Differentiation 77:492-504
Wu, Yongzhong; Zhang, Xueping; Salmon, Morgan et al. (2007) The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression. Genes Cells 12:905-18
Wu, Yongzhong; Zhang, Xueping; Salmon, Morgan et al. (2007) TGFbeta1 regulation of vimentin gene expression during differentiation of the C2C12 skeletal myogenic cell line requires Smads, AP-1 and Sp1 family members. Biochim Biophys Acta 1773:427-39
Wu, Yongzhong; Diab, Iman; Zhang, Xueping et al. (2004) Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89. Oncogene 23:168-78
Brule, Herve; Elliott, Mark; Redlak, Maria et al. (2004) Isolation and characterization of the human tRNA-(N1G37) methyltransferase (TRM5) and comparison to the Escherichia coli TrmD protein. Biochemistry 43:9243-55
Zhang, Xueping; Diab, Iman H; Zehner, Zendra E (2003) ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1. Nucleic Acids Res 31:2900-14
Wu, Yongzhong; Zhang, Xueping; Zehner, Zendra E (2003) c-Jun and the dominant-negative mutant, TAM67, induce vimentin gene expression by interacting with the activator Sp1. Oncogene 22:8891-901
Liu, Xuhui; Wu, Yongzhong; Zehner, Zendra E et al. (2003) Proteomic analysis of the tumorigenic human prostate cell line M12 after microcell-mediated transfer of chromosome 19 demonstrates reduction of vimentin. Electrophoresis 24:3445-53
Al-Maghrebi, May; Brule, Herve; Padkina, Marina et al. (2002) The 3' untranslated region of human vimentin mRNA interacts with protein complexes containing eEF-1gamma and HAX-1. Nucleic Acids Res 30:5017-28

Showing the most recent 10 out of 22 publications